ACRS Aclaris Therapeutics | Upgraded by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.89
+6.3% | $20.00 ➝ $20.00 | Neutral ➝ Buy | |
AMTX Aemetis | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.59
-1.1% | $28.00 ➝ $28.00 | Buy ➝ Buy | |
APLT Applied Therapeutics | Downgraded by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Corwin
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.87
-1.5% | | Outperform ➝ Market Perform | |
AVXL Anavex Life Sciences | Reiterated by | D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.18
+29.5% | $46.00 ➝ $46.00 | Buy ➝ Buy | |
BBIO BridgeBio Pharma | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.77
+4.8% | $45.00 ➝ $50.00 | Outperform ➝ Outperform | |
BKV BKV | Target Raised by | KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Rezvan
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $21.97
+1.3% | $23.00 ➝ $25.00 | Overweight ➝ Overweight | |
|
BLK BlackRock | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,039.70
+1.1% | $1,150.00 ➝ $1,200.00 | Buy ➝ Buy | |
BWAY BrainsWay | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.15
-1.0% | $16.00 ➝ $16.00 | Buy ➝ Buy | |
BX Blackstone | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Love
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $172.19
+0.8% | $168.00 ➝ $179.00 | Neutral ➝ Neutral | |
BZH Beazer Homes USA | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Mccanless
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $28.16
+0.9% | $45.00 | Outperform | |
CAE CAE | Upgraded by | Desjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.55
+3.3% | | Hold ➝ Buy | |
CAG Conagra Brands | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.53
+1.5% | $33.00 ➝ $32.00 | Overweight ➝ Overweight | |
CASH Pathward Financial | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.08
+0.6% | $82.00 ➝ $94.00 | Overweight ➝ Overweight | |
CCL Carnival Co. & | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.73
-4.0% | $30.00 ➝ $31.00 | Buy | |
CCL Carnival Co. & | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.73
-4.0% | $32.00 ➝ $34.00 | Buy ➝ Buy | |
CCL Carnival Co. & | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.73
-4.0% | $31.00 ➝ $32.00 | Overweight ➝ Overweight | |
CEVA CEVA | Target Raised by | Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.82
+2.3% | $31.00 ➝ $35.00 | Outperform ➝ Outperform | |
CMPX Compass Therapeutics | Initiated by | D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.51
+9.4% | $32.00 | Buy | |
CSAN Cosan | Reiterated by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.59
-0.5% | $19.00 | Buy | |
DDOG Datadog | Target Raised by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | Y. Kim
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $147.46
-1.3% | $160.00 ➝ $200.00 | Buy ➝ Buy | |
DHR Danaher | Initiated by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $229.16
+0.3% | $265.00 | Sector Perform | |
DRI Darden Restaurants | Target Raised by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $184.79
-1.5% | $193.00 ➝ $209.00 | Overweight ➝ Overweight | |
ECPG Encore Capital Group | Target Raised by | Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.76
-0.1% | $58.00 ➝ $66.00 | Outperform ➝ Outperform | |
EL Estée Lauder Companies | Reiterated by | DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.75
+0.5% | $81.00 ➝ $81.00 | Buy ➝ Buy | |
ENFN Enfusion | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.52
-1.0% | $10.00 ➝ $11.50 | Neutral ➝ Neutral | |
ENGN enGene | Initiated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.96
+2.2% | $25.00 | Buy | |
ENGN enGene | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Tuerkcan
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $5.96
+2.2% | $18.00 ➝ $18.00 | Market Outperform ➝ Market Outperform | |
ETWO E2open Parent | Target Lowered by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.62
-0.4% | $4.00 ➝ $3.00 | Hold ➝ Hold | |
EVTL Vertical Aerospace | Reiterated by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.42
-6.0% | $16.00 ➝ $16.00 | Buy ➝ Buy | |
EXEL Exelixis | Initiated by | Brookline Capital Management
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.48
+0.6% | | Buy | |
FDS FactSet Research Systems | Target Lowered by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $489.34
+1.2% | $521.00 ➝ $518.00 | Market Perform ➝ Market Perform | |
GCMG GCM Grosvenor | Upgraded by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14
+3.3% | $12.50 ➝ $14.00 | Neutral ➝ Overweight | |
GOOGL Alphabet | Reiterated by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $194.63
+1.7% | $210.00 ➝ $210.00 | Buy ➝ Buy | |
HBAN Huntington Bancshares | Reiterated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.28
-0.2% | $20.00 ➝ $20.00 | Outperform ➝ Outperform | |
HSY Hershey | Target Lowered by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.00
-0.7% | $195.00 ➝ $170.00 | Neutral | |
HUMA Humacyte | Target Raised by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.65
+0.2% | $15.00 ➝ $17.00 | Buy ➝ Buy | |
IIPR Innovative Industrial Properties | Downgraded by | BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $70.45
-4.4% | | Buy ➝ Neutral | |
IKNA Ikena Oncology | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.67
+7.7% | $2.00 | Neutral | |
JSPR Jasper Therapeutics | Reiterated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.12
+2.5% | $68.00 ➝ $68.00 | Outperform ➝ Outperform | |
KR Kroger | Reiterated by | Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.96
-1.4% | $70.00 ➝ $70.00 | Outperform ➝ Outperform | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
KROS Keros Therapeutics | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.12
+0.5% | $100.00 ➝ $43.00 | Buy ➝ Buy | |
KVYO Klaviyo | Target Raised by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.83
-2.8% | $45.00 ➝ $60.00 | Buy ➝ Buy | |
LEN Lennar | Target Lowered by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Maklari
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $138.00
-0.1% | $190.00 ➝ $162.00 | Neutral ➝ Neutral | |
LGND Ligand Pharmaceuticals | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $113.80
-0.7% | $135.00 ➝ $135.00 | Buy ➝ Buy | |
LW Lamb Weston | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.90
+2.9% | $87.00 ➝ $69.00 | Overweight ➝ Overweight | |
LXRX Lexicon Pharmaceuticals | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.83
+16.1% | | Hold ➝ Hold | |
MESO Mesoblast | Downgraded by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.23
+17.8% | | Buy ➝ Hold | |
MGPI MGP Ingredients | Target Lowered by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.85
-0.4% | $65.00 ➝ $60.00 | Buy ➝ Buy | |
MMSI Merit Medical Systems | Reiterated by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.61
-0.6% | $114.00 ➝ $114.00 | Outperform ➝ Outperform | |
MNDY monday.com | Target Lowered by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $231.85
-4.4% | $310.00 ➝ $300.00 | Buy ➝ Buy | |
MSFT Microsoft | Target Raised by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $435.25
-0.3% | $500.00 ➝ $550.00 | Buy ➝ Buy | |
MTN Vail Resorts | Reiterated by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $190.32
+3.3% | $197.00 ➝ $197.00 | Equal Weight ➝ Equal Weight | |
NBIX Neurocrine Biosciences | Reiterated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.99
+1.2% | $160.00 ➝ $160.00 | Overweight ➝ Overweight | |
NBIX Neurocrine Biosciences | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.99
+1.2% | $160.00 ➝ $165.00 | Overweight ➝ Overweight | |
NFE New Fortress Energy | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.56
+21.7% | $16.00 ➝ $17.00 | Buy ➝ Buy | |
NHI National Health Investors | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $69.06
-1.1% | $78.00 ➝ $72.00 | Hold ➝ Hold | |
NKE NIKE | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.76
-0.2% | $110.00 ➝ $105.00 | Outperform ➝ Outperform | |
NUVB Nuvation Bio | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.67
-0.4% | $5.00 | Outperform | |
NVO Novo Nordisk A/S | Target Lowered by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.71
+4.4% | $156.00 ➝ $105.00 | Outperform ➝ Outperform | |
NWSA News | Target Lowered by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.05
+0.7% | $44.00 ➝ $41.00 | Buy ➝ Buy | |
OLLI Ollie's Bargain Outlet | Reiterated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.57
-0.3% | $130.00 ➝ $130.00 | Outperform ➝ Outperform | |
OLLI Ollie's Bargain Outlet | Target Raised by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.57
-0.3% | $120.00 ➝ $130.00 | Buy ➝ Buy | |
OMER Omeros | Initiated by | D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.11
-1.9% | $36.00 | Buy | |
OWL Blue Owl Capital | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.65
+0.7% | $25.00 ➝ $27.00 | Overweight ➝ Overweight | |
PAYX Paychex | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.34
-0.1% | $135.00 ➝ $140.00 | Equal Weight ➝ Equal Weight | |
PBYI Puma Biotechnology | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.81
+2.2% | $7.00 ➝ $7.00 | Buy ➝ Buy | |
PCH PotlatchDeltic | Upgraded by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.58
+2.1% | $45.00 | Market Perform ➝ Outperform | |
PONY Pony AI | Initiated by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.39
+9.3% | $19.60 | Buy | |
PONY Pony AI | Initiated by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.39
+9.3% | $18.00 | Buy | |
REE REE Automotive | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.45
-8.1% | $15.00 ➝ $15.00 | Buy ➝ Buy | |
RMTI Rockwell Medical | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.11
+1.4% | $7.00 ➝ $7.00 | Buy ➝ Buy | |
ROP Roper Technologies | Initiated by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $524.94
-0.1% | $630.00 | Outperform | |
RVNC Revance Therapeutics | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Prasad
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.07
-0.6% | $7.00 ➝ $3.00 | Equal Weight ➝ Equal Weight | |
RYTM Rhythm Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Selvaraju
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $56.04
-0.1% | $69.00 ➝ $69.00 | Buy ➝ Buy | |
RYTM Rhythm Pharmaceuticals | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wolleben
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $56.04
-0.1% | $75.00 ➝ $75.00 | Market Outperform ➝ Market Outperform | |
SEIC SEI Investments | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $83.10
+0.4% | $77.00 ➝ $87.00 | Neutral ➝ Neutral | |
SIMO Silicon Motion Technology | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.07
+4.0% | $90.00 | Outperform | |
SLB Schlumberger | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.26
+1.2% | $60.00 ➝ $59.00 | Buy ➝ Buy | |
SMTI Sanara MedTech | Initiated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.11
+1.3% | $50.00 | Buy | |
SNOW Snowflake | Target Raised by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $161.44
-2.9% | $185.00 ➝ $205.00 | Buy ➝ Buy | |
SOUN SoundHound AI | Target Raised by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.43
-6.1% | $8.00 ➝ $26.00 | Buy ➝ Buy | |
TBBK Bancorp | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.36
+0.1% | $61.00 ➝ $64.00 | Overweight ➝ Overweight | |
TBN Tamboran Resources | Reiterated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Lear
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $18.17
+5.3% | $41.00 ➝ $41.00 | Overweight ➝ Overweight | |
TCRX TScan Therapeutics | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.01
+1.3% | $7.00 | Outperform | |
TMO Thermo Fisher Scientific | Initiated by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $525.29
+0.2% | $605.00 | Sector Perform | |
TXT Textron | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.44
-0.5% | $104.00 ➝ $95.00 | Overweight ➝ Overweight | |
UNIT Uniti Group | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.49
-3.7% | $5.50 ➝ $6.00 | Sector Perform ➝ Sector Perform | |
VNDA Vanda Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Selvaraju
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $4.68
-2.1% | $18.00 ➝ $18.00 | Buy ➝ Buy | |
VRTX Vertex Pharmaceuticals | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $405.27
+2.0% | $550.00 ➝ $460.00 | Buy ➝ Buy | |
VRTX Vertex Pharmaceuticals | Target Raised by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Harrison
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $405.27
+2.0% | $426.00 ➝ $430.00 | Sector Perform ➝ Sector Perform | |
Forced out of retirement by these trades (Ad) You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered.
Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever.
And I was more than happy to be a stay-at-home dad…
But then I discovered Gamma Pockets… and everything changed Make sure to check out Gamma Pockets HERE while it’s still widely available |
VRTX Vertex Pharmaceuticals | Target Lowered by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $405.27
+2.0% | $503.00 ➝ $500.00 | Overweight ➝ Overweight | |
VYNE VYNE Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.57
+2.8% | $5.75 ➝ $5.75 | Buy ➝ Buy | |
WAT Waters | Initiated by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $369.76
+0.4% | $430.00 | Sector Perform | |
WGO Winnebago Industries | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Albanese
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $47.99
-4.0% | $70.00 ➝ $70.00 | Buy ➝ Buy | |
WKSP Worksport | Initiated by | Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.81
-3.5% | $2.00 | Buy | |
WY Weyerhaeuser | Upgraded by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.08
+2.1% | $32.00 | Market Perform ➝ Outperform | |
